NASDAQ:IBB iShares Biotechnology ETF - IBB Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. $136.32 +0.71 (+0.52%) (As of 02/7/2023 12:00 AM ET) Add Compare Share Share Today's Range$133.90▼$136.5850-Day Range$128.39▼$138.4352-Week Range$104.29▼$138.74Volume1.41 million shsAverage Volume1.50 million shsMarket Capitalization$8.99 billionP/E RatioN/ADividend Yield0.30%Price TargetN/A ProfileChartDividendInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Basic Details Issuer BlackRock Fund NameiShares Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$7.70 billion Average Daily Volume$2.62 million Discount/Premium0.08% ETF Expenses Management Fee0.47% Other Expenses0.00% Total Expenses0.47% Fee Waiver0.00% Net Expenses0.47%Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial Geographic Exposure of IBBCurrency Exposure of IBBSector Exposure of IBBIndustry Exposure of IBB Key ExecutivesGeorge G. C. Parker Ph.D.Independent Chairman of the Board of TrusteesMichael Arthur LathamPresident, TrusteeJack GeeChief Financial Officer, TreasurerGeoffrey D. FlynnChief Operating Officer, Executive Vice PresidentBio & Compensation - Amy SchioldagerExecutive Vice PresidentIra P. ShapiroVice President, Chief Legal OfficerMatt TuckerVice PresidentBio & Compensation - Eilleen M. ClavereSecretaryCecilia H. HerbertIndependent TrusteeCharles A. HurtyIndependent TrusteeMore ExecutivesKey CompetitorsDNP Select Income FundNYSE:DNPFederal Realty Investment TrustNYSE:FRTSTORE CapitalNYSE:STORRenaissanceReNYSE:RNRLife StorageNYSE:LSIView All CompetitorsInsiders & InstitutionsMoors & Cabot Inc.Sold 359 shares on 2/7/2023Ownership: 0.044%Oppenheimer Asset Management Inc.Bought 26,455 shares on 2/7/2023Ownership: 0.040%Robbins FarleyBought 5,549 shares on 2/7/2023Ownership: 0.030%Fernwood Investment Management LLCBought 150 shares on 2/7/2023Ownership: 0.007%Financial Sense Advisors Inc.Bought 2,820 shares on 2/7/2023Ownership: 0.004%View All Institutional Transactions IBB Stock - Frequently Asked Questions How have IBB shares performed in 2023? iShares Biotechnology ETF's stock was trading at $131.29 at the start of the year. Since then, IBB shares have increased by 3.9% and is now trading at $136.42. View the best growth stocks for 2023 here. Are investors shorting iShares Biotechnology ETF? iShares Biotechnology ETF saw a drop in short interest in the month of January. As of January 15th, there was short interest totaling 9,870,000 shares, a drop of 5.5% from the December 31st total of 10,440,000 shares. Based on an average daily trading volume, of 1,772,300 shares, the days-to-cover ratio is currently 5.6 days. View iShares Biotechnology ETF's Short Interest. How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF? iShares Biotechnology ETF declared a quarterly dividend on Monday, December 12th. Stockholders of record on Wednesday, December 14th will be paid a dividend of $0.101 per share on Monday, December 19th. This represents a $0.40 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Tuesday, December 13th. This is a boost from the stock's previous quarterly dividend of $0.03. Read our dividend analysis for IBB. Is iShares Biotechnology ETF a good dividend stock? iShares Biotechnology ETF (NASDAQ:IBB) pays an annual dividend of $0.41 per share and currently has a dividend yield of 0.30%. Read our dividend analysis for IBB. When did iShares Biotechnology ETF's stock split? Shares of iShares Biotechnology ETF split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL). What is iShares Biotechnology ETF's stock symbol? iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB." Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include LPL Financial LLC (0.96%), Miracle Mile Advisors LLC (0.44%), Bank Julius Baer & Co. Ltd Zurich (0.43%), Commonwealth Equity Services LLC (0.42%), Gradient Investments LLC (0.41%) and Envestnet Asset Management Inc. (0.30%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iShares Biotechnology ETF's stock price today? One share of IBB stock can currently be purchased for approximately $136.42. How much money does iShares Biotechnology ETF make? iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $9.00 billion. This page (NASDAQ:IBB) was last updated on 2/7/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.